TKL Research, Inc. Wins Four CRO Leadership Awards
Rochelle Park, N.J.; June 30, 2016 — TKL Research, a full-service clinical research organization (CRO) with special expertise in dermatological conditions, has received four 2016 CRO Leadership Awards in the areas of Capabilities, Compatibility, Expertise and Quality from the annual Life Science Leader competition. TKL was also recognized as a leader in offering clients innovative solutions.
“For more than 20 years, TKL Research has offered clients clinical trial expertise in a range of therapeutic areas,” said Dr. Jon Anderson, TKL Research President and CEO. “As we’ve grown and expanded our operations, we’ve made strong, collaborative relationships with our clients a top priority. I am pleased for our staff to be recognized for the success of their efforts.”
The CRO Leadership Awards were developed by Life Science Leader and represent the results of independent research conducted by Industry Standard Reports. For the awards, 65 clinical research organizations were evaluated on 27 criteria by industry professionals who had done business with them in the last 18 months.
“The CROs receiving an award this year are truly at the top of their class and are deserving of the recognition they receive,” said Ed Miseta, Executive Editor, Life Science Leader. “Being a top performer in any of these categories shows a level of expertise and commitment to clinical trials and serving the needs of biopharmaceutical companies and their patients.”
TKL Research provides comprehensive clinical trial management services for Phase 1-4 clinical research studies, including an inpatient Phase 1 facility and outpatient specialized research clinics. TKL has broad capabilities that include a unique patient recruitment paradigm to shorten timelines as well as minimal staff turnover and deep expertise in a number of therapeutic areas.
For more information, visit the company’s website at TKLResearch.com.
About TKL Research, Inc.
TKL Research is a full-service, international CRO offering deep expertise in a full spectrum of dermatological indications as well as a complete range of clinical trial management services from Phase 1 to multicenter international studies. TKL’s emphasis on recruitment and site selection enables studies to be filled and initiated sooner, shortening timelines and reducing costs for a wide range of studies in dermatology and other therapeutic areas.
“For more than 20 years, TKL Research has offered clients clinical trial expertise in a range of therapeutic areas,” said Dr. Jon Anderson, TKL Research President and CEO. “As we’ve grown and expanded our operations, we’ve made strong, collaborative relationships with our clients a top priority. I am pleased for our staff to be recognized for the success of their efforts.”
The CRO Leadership Awards were developed by Life Science Leader and represent the results of independent research conducted by Industry Standard Reports. For the awards, 65 clinical research organizations were evaluated on 27 criteria by industry professionals who had done business with them in the last 18 months.
“The CROs receiving an award this year are truly at the top of their class and are deserving of the recognition they receive,” said Ed Miseta, Executive Editor, Life Science Leader. “Being a top performer in any of these categories shows a level of expertise and commitment to clinical trials and serving the needs of biopharmaceutical companies and their patients.”
TKL Research provides comprehensive clinical trial management services for Phase 1-4 clinical research studies, including an inpatient Phase 1 facility and outpatient specialized research clinics. TKL has broad capabilities that include a unique patient recruitment paradigm to shorten timelines as well as minimal staff turnover and deep expertise in a number of therapeutic areas.
For more information, visit the company’s website at TKLResearch.com.
About TKL Research, Inc.
TKL Research is a full-service, international CRO offering deep expertise in a full spectrum of dermatological indications as well as a complete range of clinical trial management services from Phase 1 to multicenter international studies. TKL’s emphasis on recruitment and site selection enables studies to be filled and initiated sooner, shortening timelines and reducing costs for a wide range of studies in dermatology and other therapeutic areas.